In vitroassessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P450enzyme identification, inhibition, and induction studies

Yan Li; Diansong Zhou; Stephen S. Ferguson; Peter Dorff; Thomas R. Simpson; Scott W. Grimm

doi:10.3109/00498254.2010.512670

In vitroassessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P450enzyme identification, inhibition, and induction studies

Xenobiotica ◽

10.3109/00498254.2010.512670 ◽

2010 ◽

Vol 40 (11) ◽

pp. 721-729 ◽

Cited By ~ 9

Author(s):

Yan Li ◽

Diansong Zhou ◽

Stephen S. Ferguson ◽

Peter Dorff ◽

Thomas R. Simpson ◽

...

Keyword(s):

Drug Interaction ◽

Receptor Antagonist ◽

Interaction Potential ◽

Metabolic Drug ◽

Drug Drug Interaction ◽

Neurokinin 3 Receptor

Download Full-text

Evaluation of the drug–drug interaction potential for trazpiroben (TAK-906), a D2/D3 receptor antagonist for gastroparesis, towards cytochrome P450s and transporters

Xenobiotica ◽

10.1080/00498254.2021.1912438 ◽

2021 ◽

pp. 1-12

Author(s):

Mitsuhiro Nishihara ◽

Diane Ramsden ◽

Suresh K. Balani

Keyword(s):

Drug Interaction ◽

Receptor Antagonist ◽

Interaction Potential ◽

Cytochrome P450s ◽

D3 Receptor ◽

Drug Drug Interaction

Download Full-text

Preliminary in vitro approach to evaluate the drug-drug interaction potential of EST73502, a dual µ-opioid receptor partial agonist and σ1 receptor antagonist

Xenobiotica ◽

10.1080/00498254.2021.1877850 ◽

2021 ◽

pp. 1-12

Author(s):

Eva Ayet ◽

Sandra Yeste ◽

Raquel F. Reinoso ◽

María José Pretel ◽

Ariadna Balada ◽

...

Keyword(s):

Drug Interaction ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Interaction Potential ◽

Partial Agonist ◽

Σ1 Receptor ◽

Drug Drug Interaction

Download Full-text

In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies

Drug Metabolism and Disposition ◽

10.1124/dmd.109.029694 ◽

2009 ◽

Vol 38 (3) ◽

pp. 448-458 ◽

Cited By ~ 145

Author(s):

Lifei Wang ◽

Donglu Zhang ◽

Nirmala Raghavan ◽

Ming Yao ◽

Li Ma ◽

...

Keyword(s):

Cytochrome P450 ◽

Drug Interaction ◽

Interaction Potential ◽

Metabolic Drug ◽

In Vitro Assessment ◽

Drug Drug Interaction

Download Full-text

Drug–drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist

Xenobiotica ◽

10.1080/00498254.2021.1918361 ◽

2021 ◽

pp. 1-10

Author(s):

Shuichi Terasaka ◽

Kenji Hachiuma ◽

Yoko Mano ◽

Koichi Onishi ◽

Iwao Kitajima ◽

...

Keyword(s):

Drug Interaction ◽

Receptor Antagonist ◽

Interaction Potential ◽

Clinical Pharmacokinetics ◽

Histamine H3 Receptor ◽

H3 Receptor ◽

Drug Drug Interaction ◽

Histamine H3

Download Full-text

Correction to “In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies”

Drug Metabolism and Disposition ◽

10.1124/dmd.109.000019 ◽

2010 ◽

Vol 38 (5) ◽

pp. 887-887

Keyword(s):

Cytochrome P450 ◽

Drug Interaction ◽

Interaction Potential ◽

Metabolic Drug ◽

In Vitro Assessment ◽

Drug Drug Interaction

Download Full-text

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1996-6 ◽

2012 ◽

Vol 71 (1) ◽

pp. 193-202 ◽

Cited By ~ 12

Author(s):

Patricia M. LoRusso ◽

Sarina A. Piha-Paul ◽

Monica Mita ◽

A. Dimitrios Colevas ◽

Vikram Malhi ◽

...

Keyword(s):

Drug Interaction ◽

Oral Contraceptive ◽

Solid Tumors ◽

Interaction Potential ◽

Locally Advanced ◽

Combined Oral Contraceptive ◽

Pharmacokinetic Assessment ◽

Drug Drug Interaction

Download Full-text

The bioequivalence of fixed‐dose combination tablets of bisoprolol and ramipril and its drug‐drug interaction potential

Clinical and Translational Science ◽

10.1111/cts.13128 ◽

2021 ◽

Author(s):

Jan Sus ◽

Jade Huguet ◽

Jan Bosak ◽

Beatrice Setnik ◽

Tomas Hauser ◽

...

Keyword(s):

Drug Interaction ◽

Interaction Potential ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Drug Drug Interaction

Download Full-text

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13817 ◽

2018 ◽

Vol 85 (3) ◽

pp. 530-539 ◽

Cited By ~ 1

Author(s):

Ying Ou ◽

Yang Xu ◽

Lia Gore ◽

R. Donald Harvey ◽

Alain Mita ◽

...

Keyword(s):

Drug Interaction ◽

Interaction Potential ◽

Pharmacokinetic Modelling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based Pharmacokinetic Modelling ◽

Advanced Malignancies ◽

Physiologically Based ◽

Drug Drug Interaction

Download Full-text

Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor

Drug Metabolism and Disposition ◽

10.1124/dmd.115.063743 ◽

2015 ◽

Vol 43 (6) ◽

pp. 864-869 ◽

Cited By ~ 15

Author(s):

Edna F. Choo ◽

Sarah Woolsey ◽

Kevin DeMent ◽

Justin Ly ◽

Kirsten Messick ◽

...

Keyword(s):

Drug Interaction ◽

Transgenic Mouse ◽

Mouse Models ◽

Interaction Potential ◽

Mek Inhibitor ◽

Transgenic Mouse Models ◽

Drug Drug Interaction

Download Full-text

Clinical Pharmacokinetics and Drug-Drug Interaction Potential for Coadministered SCY-078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.588 ◽

2018 ◽

Vol 8 (1) ◽

pp. 60-69 ◽

Cited By ~ 9

Author(s):

Stephen Wring ◽

Gail Murphy ◽

George Atiee ◽

Christy Corr ◽

Michele Hyman ◽

...

Keyword(s):

Drug Interaction ◽

Interaction Potential ◽

Clinical Pharmacokinetics ◽

Glucan Synthase ◽

Drug Drug Interaction ◽

Synthase Inhibitor

Download Full-text